Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsAnaphylactic

anaphylactic

Healthcare

Novavax Prepared to Deliver Protein-based Monovalent XBB COVID Vaccine Consistent with FDA VRBPAC Recommendation for the Fall

News Desk -
Novavax, Inc., a global company advancing protein-based vaccines with its novel Matrix-M adjuvant, participated in U.S. Food and Drug Administration (FDA) Vaccines and Related...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us